ArticlePituitary2026

Letter to the editor: Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort.

Neslihan Koray Fedai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.